Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

NCT07527819 is registered in ClinicalTrials.gov with Peter MacCallum Cancer Centre, Australia as lead sponsor.

NCT NCT07527819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07527819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)
Lead sponsor
Peter MacCallum Cancer Centre, Australia
Phase
Observational
Overall status
Not yet recruiting
Start date
April 8, 2026
Completion date
December 31, 2031
Enrollment
75 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

triple negative breast cancer (tnbc)